APA (7th ed.) Citation

Luef, G., Rauchenzauner, M., Waldmann, M., Sturm, W., Sandhofer, A., Seppi, K., . . . Lechleitner, M. (2009). Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment. Epilepsy Research, 86(1), 42. https://doi.org/10.1016/j.eplepsyres.2009.04.004

Chicago Style (17th ed.) Citation

Luef, G., et al. "Non-alcoholic Fatty Liver Disease (NAFLD), Insulin Resistance and Lipid Profile in Antiepileptic Drug Treatment." Epilepsy Research 86, no. 1 (2009): 42. https://doi.org/10.1016/j.eplepsyres.2009.04.004.

MLA (9th ed.) Citation

Luef, G., et al. "Non-alcoholic Fatty Liver Disease (NAFLD), Insulin Resistance and Lipid Profile in Antiepileptic Drug Treatment." Epilepsy Research, vol. 86, no. 1, 2009, p. 42, https://doi.org/10.1016/j.eplepsyres.2009.04.004.